Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin's Lymphoma.

导出 LinkOut

翻译打印收藏纠错

作者： Zhitao,Ying ^[1] ; Ting,He ^[2] ; Xiaopei,Wang ^[1] ; Wen,Zheng ^[1] ; Ningjing,Lin ^[1] ; Meifeng,Tu ^[1] ; Yan,Xie ^[1] ; Lingyan,Ping ^[1] ; Chen,Zhang ^[1] ; Weiping,Liu ^[1] ; Lijuan,Deng ^[1] ; Feifei,Qi ^[2] ; Yanping,Ding ^[2] ; Xin-An,Lu ^[2] ; Yuqin,Song ^[1] ; Jun,Zhu ^[1]

作者单位： Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China. ^[1] Immunochina Pharmaceuticals Co., Ltd., Beijing, China. ^[2]

关键词 B cell non-Hodgkin’s lymphoma CD19-targeted chimeric antigen receptor-T cells co-stimulatory domain

DOI 10.1016/j.omto.2019.08.002

PMID 31650026

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Molecular therapy oncolytics

2019年15卷

60-68页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin's Lymphoma.

Molecular therapy oncolytics

相似文献

Molecular therapy oncolytics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin's Lymphoma.

Molecular therapy oncolytics

相似文献

Molecular therapy oncolytics

相关期刊

检索历史清除